You are here

Press Releases

Oct 08, 2014

Branford, CT - New Haven Pharmaceuticals, Inc. (the "Company" or "NHP"), a privately-held specialty pharmaceuticals company, has strengthened its management team with the appointment of two experienced pharmaceutical executives to newly-created positions: Dr. Jeffrey Patrick as Chief Scientific Officer, and Michael Richardson as Chief Business Officer.

Sep 11, 2014

Specialty pharmaceuticals company announces submission of New Drug Application to the FDA.


Subscribe to News